Navigating the unique CMC challenges of oral anaerobic live biotherapeutics
European Pharmaceutical Review
FEBRUARY 14, 2024
Firstly, the pharmacological response to LBPs does not follow traditional pharmacokinetic principles. About the authors Mike Frodsham has been the Chief Technical Officer for SGS Quay Pharma for over 18 years and holds over 23 years of experience in drug product development. 2015; 69(1):381–403 5. 2021; 19:100306 4.
Let's personalize your content